Objective To analyze clinical efficacy of inhalation of budesonide and formoterol on cough variant asthma.
目的探讨布地耐德与福美特罗吸入治疗咳嗽变异性哮喘的临床疗效。
Limitations of this study include lack of a formoterol therapy-alone treatment group and inability to determine compliance.
此项研究的局限性主要在于缺乏福莫特罗单纯治疗组和对于决定的依从性的无能为力。
Objective To study the clinical efficacy and adverse effects of Formoterol in patients with mild and moderate asthmatic episodic attack.
目的临床观察富马酸福莫特罗（ 安通克） 片剂治疗轻、中度支气管哮喘急性发作的临床疗效和不良反应。
The formoterol and Corticosteroid Establishing Therapy study compared the effects of a 4-fold increase in the budesonide dose with and without formoterol.
福莫特罗和皮质醇疗效证实“研究比较布地奈德剂量增加4倍后加入与不加入福莫特罗的效果。”
Web sites of clinical trial registers were checked for unpublished trial data and Food and Drug Administration submissions in relation to formoterol were also checked.
在临床试验注册网站查询未公布的试验数据，对上交到美国食品与药物管理局的与福莫特罗有关的资料也进行查证。
The drug preparation containing the active ingredients of the ambroxol and the formoterol is characterized by stable property, convenient use, and being applicable for large-scale production.
本发明的含氨溴索与福莫特罗活性成分的药物制剂具有性质稳定，使用方便，适用于大生产化的特点。
The drug preparation containing the active ingredients of the ambroxol and the formoterol is characterized by stable property, convenient use, and being applicable for large-scale production.
本发明的含氨溴索与福莫特罗活性成分的药物制剂具有性质稳定，使用方便，适用于大生产化的特点。
应用推荐